Increased complications in patients who test COVID-19 positive after elective surgery and implications for pre and postoperative screening.
AuthorPrasad, Nikhil K
Englum, Brian R
Turner, Douglas J
Sorkin, John D
Lal, Brajesh K
JournalAmerican Journal of Surgery
MetadataShow full item record
AbstractBackground: The COVID-19 pandemic has necessitated the adoption of protocols to minimize risk of periprocedural complications associated with SARS-CoV-2 infection. This typically involves a preoperative symptom screen and nasal swab RT-PCR test for viral RNA. Asymptomatic patients with a negative COVID-19 test are cleared for surgery. However, little is known about the rate of postoperative COVID-19 positivity among elective surgical patients, risk factors for this group and rate of complications. Methods: This prospective multicenter study included all patients undergoing elective surgery at 170 Veterans Health Administration (VA) hospitals across the United States. Patients were divided into groups based on first positive COVID-19 test within 30 days after surgery (COVID[-/+]), before surgery (COVID[+/-]) or negative throughout (COVID[-/-]). The cumulative incidence, risk factors for and complications of COVID[-/+], were estimated using univariate analysis, exact matching, and multivariable regression. Results: Between March 1 and December 1, 2020 90,093 patients underwent elective surgery. Of these, 60,853 met inclusion criteria, of which 310 (0.5%) were in the COVID[-/+] group. Adjusted multivariable logistic regression identified female sex, end stage renal disease, chronic obstructive pulmonary disease, congestive heart failure, cancer, cirrhosis, and undergoing neurosurgical procedures as risk factors for being in the COVID[-/+] group. After matching on current procedural terminology code and month of procedure, multivariable Poisson regression estimated the complication rate ratio for the COVID[-/+] group vs. COVID[-/-] to be 8.4 (C.I. 4.9-14.4) for pulmonary complications, 3.0 (2.2, 4.1) for major complications, and 2.6 (1.9, 3.4) for any complication. Discussion: Despite preoperative COVID-19 screening, there remains a risk of COVID infection within 30 days after elective surgery. This risk is increased for patients with a high comorbidity burden and those undergoing neurosurgical procedures. Higher intensity preoperative screening and closer postoperative monitoring is warranted in such patients because they have a significantly elevated risk of postoperative complications.
Rights/TermsCopyright © 2021. Published by Elsevier Inc.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/17979
- Periprocedural complications in patients with SARS-CoV-2 infection compared to those without infection: A nationwide propensity-matched analysis.
- Authors: Lal BK, Prasad NK, Englum BR, Turner DJ, Siddiqui T, Carlin MM, Lake R, Sorkin JD
- Issue date: 2021 Aug
- Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic.
- Authors: COVIDSurg Collaborative
- Issue date: 2021 Jan 27
- Complications and mortality in a cohort of patients undergoing emergency and elective surgery with perioperative SARS-CoV-2 infection: an Italian multicenter study. Teachings of Phase 1 to be brought in Phase 2 pandemic.
- Authors: De Luca M, Sartori A, Vitiello A, Piatto G, Noaro G, Olmi S, Foschi D, De Re L, Zappa M, Sarro G, Rivolta U, Giraudo G, Borghi F, Pozzo G, Sorisio V, Pignata G, Greco PA, Sisti V, Campagnaro T, Guglielmi A, Andreuccetti J, Di Leo A, Lauro E, Ricci F, Musella M, Zizzo M, Bonacini S, Podda M, Pisanu A, Coletta P, Guerrieri M, Caracino V, Basti M, Pilone V, Raffaelli M, Oragano L
- Issue date: 2021 Apr
- Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study.
- Authors: COVIDSurg Collaborative, GlobalSurg Collaborative
- Issue date: 2021 Nov
- Early postoperative outcomes among patients with delayed surgeries after preoperative positive test for SARS-CoV-2: A case-control study from a single institution.
- Authors: Baiocchi G, Aguiar S Jr, Duprat JP, Coimbra FJF, Makdissi FB, Vartanian JG, Zequi SC, Gross JL, Nakagawa SA, Yazbek G, Diniz TP, Gonçalves BT, Zurstrassen CE, Campos HGDA, Joaquim EHG, França E Silva IA, Kowalski LP
- Issue date: 2021 Mar